Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EZH2 in Bladder Cancer, a Promising Therapeutic Target

13 Nov 2015

Abstract excerpt

Bladder Cancer (BC) represents a current clinical and social challenge. The recent studies aimed to describe the genomic landscape of BC have underscored the relevance of epigenetic alterations in the pathogenesis of these tumors. Among the epigenetic alterations, histone modifications occupied a central role not only in cancer, but also in normal organism homeostasis and development. EZH2 (Enhancer of Zeste...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer-related molecular mechanisms research
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26580594
DOI: 10.3390/ijms161126000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EZH2 in Bladder Cancer, a Promising Therapeutic TargetPMID 26580594Read ↗

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets MeetSemantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?Semantic proximity Read ↗

Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.Semantic proximity Read ↗

Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder CancerSemantic proximity Read ↗

EZH2-associated tumor malignancy: A prominent target for cancer treatment.Semantic proximity Read ↗

Association of Enhancer of Zeste 2 (EZH2) Genotypes with Bladder Cancer Risk in Taiwan.Semantic proximity Read ↗

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder CancerSemantic proximity Read ↗

Review of recent molecular pathology of bladder urothelial carcinomaSemantic proximity Read ↗

5hmC and TET2 Dysregulation in Bladder Cancer: Diagnostic and Prognostic ImplicationsSemantic proximity Read ↗

Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.